A Study to Assess the Safety, Efficacy, and Pharmacokinetics of Miricorilant (CORT118335) in Obese Adults With Schizophrenia or Bipolar Disorder Treated With Antipsychotic Medications
Clinical trial NCT03818256 · COMPLETED
Trial details
- NCT number
- NCT03818256
- Sponsor
- Corcept Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-04
- Primary completion
- 2022-06-17
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.